Notably, BK channel dysfunction is also reported in other genetic diseases such as the fragile X syndrome (Deng and Klyachko, 2016), suggesting that BK CAKCs can be a potential general target for therapeutic intervention (Griguoli et al., 2016). The gene discussed is KCNMA1; the disease is fragile X syndrome.